GlassScriptPhysician profile
Michael J Palliser
NPI 1427154319
$1,098.26
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $178 · 2022: $489.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $180.00 | 2019-2022 | |
| Orthofix Medical, INC. | $138.39 | 2020 | |
| Royal Biologics, INC. | $119.39 | 2019 | |
| Medline Industries LP | $109.32 | 2019 | |
| Angiodynamics, INC. | $107.22 | 2022 | |
| Tactile Systems Technology INC | $106.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $98.36 | 2022 | |
| Cardiovascular Systems INC. | $90.92 | 2022 | |
| Collaborative Care Diagnostics, LLC | $47.99 | 2022 | |
| Abbott Laboratories | $46.02 | 2022 | |
| Wright Medical Technology, INC. | $39.93 | 2020 | |
| Organogenesis INC. | $14.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Palliser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.